Success Stories: EB-1A Approved for Postdoctoral Research Scholar in Pennsylvania in the Field of Cellular and Molecular Biology

Client’s Testimonial:

Thank you for your professionalism all through out. I may perhaps be one of the odd ones among your client who took forever to draft my summary and research background but once that was done. Your team did an excellent job that is hard to describe in simple words. Right from drafting such nice glorious while maintaining the accuracy of the scientific letters of recommendation to help my referees to walking me though each step of the way. Letting me know what to expect and when to expect it. Giving me unbiased advise even thought it may not have made business sense for example you warned me each time I asked you to do premium processing that statistically there would be more chances of a RFE under premium processing. Then you also made sure all the documents were in order. Most importantly you never made any excuse over holidays or anything regarding the time line of things you promised in your client agreement. I received each and every work on time or before time. Your team answered every question in a timely manner and went out of the way to accommodate some requests. I would recommend your services to anyone without any reservation. Thank you for helping me on my path to getting GREENED!

On April 9, 2015, We Received Another EB1-A (Alien of Extraordinary Ability) Approval for a Postdoctoral Research Scholar in the Field of Cellular and Molecular Biology (Approval Notice)

General Field: Cellular and Molecular Biology

Position at the Time of Case Filing: Postdoctoral Research Scholar

Country of Origin: India

Service Center: Texas Service Center (TSC)

State of Residence at the Time of Filing: Pennsylvania

Approval Notice Date: April 9, 2015

Processing Time: 16 Days (3 days after Requesting Premium Processing)

Case Summary:

In this case, the client that we had the opportunity to work with was a postdoctoral research scholar from India in the field of cellular and molecular biology. [Client’s] specialized research has focused on cellular signaling and its role in muscle wasting and the development of cancerous tumors. His work had resulted in 17 peer-reviewed scientific articles and numerous presentations at national and international conferences; at the time that his case was filed, his publications had been cited at least 200 times by independent and leading researchers from prestigious institutions and organizations around the world, indicating the major significance of his work. He had also reviewed over 15 manuscripts for distinctive, internationally-circulated journals. His superior level of expertise was confirmed in the following quote from an independent recommender, “I have worked very closely with him for about 10 years, and his contributions to this research project have resulted in advancements that will improve the lives of millions of people. Continuing to support [client’s] research is investing in a more complete understanding of the mechanisms of sepsis in particular and muscle wasting in general, which is necessary for the eventual elimination of this deadly complication. Being an accomplished researcher and an expert in the field, it is important he is able to continue his research work.” It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that he sought to remain in the United States to continue work in the area of cellular and molecular biology, and that his continued research would substantially and prospectively benefit the United States. With the proof and documentation that we provided, his case was approved in 16 days.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 47,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 47,000 in 2023.